RHOA and cancer: In the present study, we investigated the GOF mechanism through which certain p53 missense mutants induce the transformed phenotype and identify a paradigm for cancer driver mutations that act indirectly to hyperactivate wild-type RhoA mechano-signaling to levels required for oncogenic TEAD/YAP transcription.